Disrupting CDK9 activity suppresses triple-negative breast cancer and is enhanced by EGFR Inhibition
干扰 CDK9 活性可抑制三阴性乳腺癌，而 EGFR 抑制剂可增强这种抑制作用。
期刊:Cellular Oncology
影响因子:4.8
doi:10.1007/s13402-025-01154-6
van der Noord, Vera E; McLaughlin, Ronan P; Karuntu, Jessica S; He, Jichao; Timmermans, A Mieke; Basnet, Sunita K C; Long, Yi; Diab, Sarah Al Haj; Tadesse, Solomon; Proost, Natalie; van Gerwen, Bastiaan; Siteur, Bjørn; van de Ven, Marieke; Pont, Chantal; Le Dévédec, Sylvia E; Martens, John W M; Wang, Shudong; Zhang, Yinghui; van de Water, Bob
